METAVIA INC. Lessee, Operating Lease, Liability, to be Paid, Year One
METAVIA INC. (MTVA) had Lessee, Operating Lease, Liability, to be Paid, Year One of $92.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-26
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $92.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $89.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $86.00K.
- 2023-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $86.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $92.00K 10-K · filed 2026-03-26 |
| 2024-12-31 | $89.00K 10-K · filed 2025-03-20 |
| 2023-12-31 | $86.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | $86.00K 10-Q · filed 2023-11-13 |
| 2022-03-31 | $32.00K 10-Q · filed 2022-05-13 |
| 2021-09-30 | $8.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $16.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $24.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $32.00K 10-K · filed 2021-04-15 |
| 2020-09-30 | $8.00K 10-Q · filed 2020-11-13 |
| 2019-12-31 | $32.00K 10-K · filed 2020-03-30 |
| 2019-06-30 | $18.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $45.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |